Neptune Wellness Solutions Inc.
Neptune Wellness Solutions Inc.
Your view on NEPTF
Overview
What the company does, where it operates, and who runs it.
About Neptune Wellness Solutions Inc.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Michael A. de Geus
- Headquarters
- 545 Promenade du Centropolis, Laval, QC, CA
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Michael A. de Geus
- Headquarters
- 545 Promenade du Centropolis, Laval, QC, CA
Neptune Wellness Solutions Inc. operates as a consumer packaged goods company in Canada, the United States, and internationally.
It's product portfolio includes omega-3 fish oils and other nutritional products, as well as softgel solutions under the Biodroga brand; and provides MaxSimil, an omega-3 fatty acid delivery technology that uses enzymes to predigest omega-3 fatty acids.
The company offers vegan multi-omega gummies and soft gels under the Forest Remedies brand; and organic baby food products under the Sprout brands. It offers its products through distributors, retail outlets, and grocery stores, as well as online on forestremedies.com and sproutorganics.com, and e-commerce sites.
Neptune Wellness Solutions Inc. was incorporated in 1998 and is headquartered in Laval, Canada.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Neptune Wellness Solutions Inc., and the rating behind it. NEPTF last traded at $0.0001; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Neptune Wellness Solutions Inc.. Starting points for Neptune Wellness Solutions Inc.: EPS -$0.51, beta 2.44 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Neptune Wellness Solutions Inc.. Neptune Wellness Solutions Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Neptune Wellness Solutions Inc.. Trailing twelve-month EPS for Neptune Wellness Solutions Inc. stands at -$0.51. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Neptune Wellness Solutions Inc.. Neptune Wellness Solutions Inc. has reported as a listed company since 2007. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Neptune Wellness Solutions Inc. valued side by side against its closest peers. Neptune Wellness Solutions Inc. is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Neptune Wellness Solutions Inc., and how their positions are changing. At a $453 market value, institutional positions materially move Neptune Wellness Solutions Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Neptune Wellness Solutions Inc. executives and directors. Shares of Neptune Wellness Solutions Inc. have traded between $0.0001 and $0.03 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Neptune Wellness Solutions Inc.. Neptune Wellness Solutions Inc. is a $453 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Neptune Wellness Solutions Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Neptune Wellness Solutions Inc.. Coverage tracks Neptune Wellness Solutions Inc. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.